ALFP Debate: Should Experiential Education Represent At Least 50% of the PharmD Curriculum?
Related Experiment Video
Updated: Nov 1, 2026

Project-Based Learning Guidelines for Health Sciences Students: An Analysis with Data Mining and Qualitative Techniques
Published on: December 9, 2022
Michelle Seegert1, Kirk E Evoy2, Stacy Brown3
1The University of Toledo College of Pharmacy & Pharmaceutical Sciences.
Objective:
Experiential education (EE), including Introductory Pharmacy Practice Experiences (IPPEs) and Advanced Pharmacy Practice Experiences (APPEs), traditionally comprises approximately 30-39% of most Doctor of Pharmacy (PharmD) curricula. This article discusses the pros and cons of revising PharmD education such that EE represents at least 50% of the curriculum, a question debated as part of the Academic Leadership Fellows Program (ALFP).
Findings:
The pro perspective highlights the growing complexity of pharmacists' roles, alignment with evolving accreditation expectations, declining NAPLEX pass rates, and the potential for innovation in experiential learning. The con perspective raises concerns about inconsistent site quality, resource constraints, and the potential unintended consequences of increasing experiential hours without system-wide reform.
Summary:
Determining the optimal proportion of EE in the PharmD curriculum requires balancing the evolving demands of pharmacy practice with institutional capacity and resource constraints. In determining the construct and amount of EE in the curricula, the Pharmacy Academy and accreditors should collaboratively define and support rigorous, sustainable models of high-quality experiential learning that reflect institutional variation, preceptor capacity, and program flexibility.
Related Concept Videos
Biopharmaceutics and Pharmacokinetics: Overview
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
Drug Control Governance: Regulatory Bodies and Their Impact
Pharmaceutical Poisoning: Potential Scenarios
